z-logo
open-access-imgOpen Access
ECG markers of malignant arrhythmias and in‐hospital outcome of COVID‐19 pneumonia
Author(s) -
Shaghee Foaad,
Nafakhi Hussein,
Alareedh Mohammed,
Nafakhi Ahmed,
AlButhabhak Karrar
Publication year - 2021
Publication title -
journal of arrhythmia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.463
H-Index - 21
eISSN - 1883-2148
pISSN - 1880-4276
DOI - 10.1002/joa3.12506
Subject(s) - medicine , qt interval , pneumonia , cardiology , mechanical ventilation , repolarization , retrospective cohort study , electrophysiology
Background ECG abnormalities associated with COVID‐19 pneumonia and adverse outcome are undefined and poorly described in prior studies. Objectives To assess the predictive role of baseline ECG markers of increased risk of malignant arrhythmias and cardiac death for adverse in‐hospital outcomes. Patients and methods A retrospective study included 93 patients of newly diagnosed COVID‐19 with features consistent with pneumonia who were admitted to the hospital from August 20 to September 20, 2020. The main outcomes were defined as receiving mechanical ventilation, in‐hospital cardiac arrest, length of ICU stay, and degree of lung damage according to computed tomography (CT) score. Results Increased QTc (QT corrected) interval, Tp‐e (T from peak to end) interval, and transmural dispersion of repolarization (TDR) were independent predictors of prolonged ICU stay ( P  < .0001) after adjustment for baseline clinical characteristics. Increasing age ( P  < .0001) followed by increased QTc interval ( P  = .02) and history of chronic lung disease ( P  = .04) were independent predictors of extensive lung damage. The independent predictors for in‐hospital cardiac arrest were increased QTc ( P  = .02) followed by increasing age ( P  = .04) and increased Tp‐e interval ( P  = .04). Conclusion Repolarization abnormalities on baseline ECG may be useful prognostic markers in patients with COVID‐19 pneumonia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here